Evidence map›Paper›PMID 19422382›Full record

ArticleBritish journal of pharmacology2009

Ca2+/calcineurin regulation of cloned vascular K ATP channels: crosstalk with the protein kinase A pathway.

N N Orie, A M Thomas, B A Perrino, A Tinker, L H Clapp

Open access · bronzeAbstract read
In one paragraph

Article in British journal of pharmacology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Review
  3. A cellular atlas of calcineurin signaling.Biochimica et biophysica acta. Molecular cell research · 2023
    Review
  4. A Review of Calcineurin Biophysics with Implications for Cardiac Physiology.International journal of molecular sciences · 2021
    Review
  5. Article
  6. Review
  7. KATP Channels in the Cardiovascular System.Physiological reviews · 2016
    Review
  8. Article
  9. Calcineurin upregulates local Ca(2+) signaling through ryanodine receptor-1 in airway smooth muscle cells.American journal of physiology. Lung cellular and molecular physiology · 2014
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. K(ATP) channel action in vascular tone regulation: from genetics to diseases.Sheng li xue bao : [Acta physiologica Sinica] · 2012
    Review
  15. Cyclic nucleotide-dependent relaxation pathways in vascular smooth muscle.Cellular and molecular life sciences : CMLS · 2012
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Endothelium in pharmacology: 30 years on.British journal of pharmacology · 2009
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

N N OrieBHF Laboratories, Department of Medicine, University College, London, UK.
A M Thomas
B A Perrino
A Tinker
L H Clapp
University College London · GBUniversity of Nevada, Reno · US

Funding

British Heart Foundation PG/07/078/2355British Heart Foundation RG/10/10/28447Medical Research Council G117/440
6 · The paper itself

Abstract

background and purposeVascular ATP-sensitive potassium (K(ATP)) channels are activated by cyclic AMP elevating vasodilators through protein kinase A (PKA). Direct channel phosphorylation is a critical mechanism, though the phosphatase opposing these effects is unknown. Previously, we reported that calcineurin, a Ca(2+)-dependent phosphatase, inhibits K(ATP) channels, though neither the site nor the calcineurin isoform involved is established. Given that the type-2 regulatory (RII) subunit of PKA is a substrate for calcineurin we considered whether calcineurin regulates channel activity through interacting with PKA. EXPERIMENTAL APPROACH: Whole-cell recordings were made in HEK-293 cells stably expressing the vascular K(ATP) channel (K(IR)6.1/SUR2B). The effect of intracellular Ca(2+) and modulators of the calcineurin and PKA pathway on glibenclamide-sensitive currents were examined. KEY

resultsConstitutively active calcineurin A alpha but not A beta significantly attenuated K(ATP) currents activated by low intracellular Ca(2+), whereas calcineurin inhibitors had the opposite effect. PKA inhibitors reduced basal K(ATP) currents and responses to calcineurin inhibitors, consistent with the notion that some calcineurin action involves inhibition of PKA. However, raising intracellular Ca(2+) (equivalent to increasing calcineurin activity), almost completely inhibited K(ATP) channel activation induced by the catalytic subunit of PKA, whose enzymatic activity is independent of the RII subunit. In vitro phosphorylation experiments showed calcineurin could directly dephosphorylate a site in Kir6.1 that was previously phosphorylated by PKA. CONCLUSIONS AND IMPLICATIONS: Calcineurin A alpha regulates K(IR)6.1/SUR2B by inhibiting PKA-dependent phosphorylation of the channel as well as PKA itself. Such a mechanism is likely to directly oppose the action of vasodilators on the K(ATP) channel.

Indexed as

CalcineurinCalcineurin InhibitorsCalciumCell LineCloning, MolecularCyclic AMP-Dependent Protein KinasesHumansIsoenzymesMembrane PotentialsModels, BiologicalMuscle, Smooth, VascularPatch-Clamp TechniquesPhosphorylationPotassium Channel BlockersPotassium Channels, Inwardly RectifyingCalcineurinCalcineurin InhibitorsCalciumCyclic AMP-Dependent Protein KinasesIsoenzymesPotassium Channel BlockersPotassium Channels, Inwardly Rectifying

Identifiers

PMID19422382
PMCPMC2707968
OpenAlexW1527519042

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.